Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) have opposite actions on the gallbladder; PACAP induces contraction, whereas VIP induces relaxation. Here, we have attempted to identify key residues responsible for their interactions with PACAP (PAC 1) and VIP (VPAC) receptors in the guinea pig gallbladder. We synthesized PACAP-27/VIP hybrid peptides and compared their actions on isolated guinea pig gallbladder smooth muscle strips using isotonic transducers. ]VIP, induced relaxation. In the presence of a PAC1 receptor antagonist, PACAP(6 -38), the contractile response to PACAP-27 was inhibited and relaxation became evident. RT-PCR analysis revealed abundant expressions of PAC1 receptor, "hop" splice variant, and VPAC1 and VPAC2 receptor mRNAs in the guinea pig gallbladder. In conclusion, PACAP-27 induces contraction of the gallbladder via PAC1/hop receptors. Gly 4 and Ile 5 are the key NH2-terminal residues of PACAP-27 that distinguish PAC1/hop receptors from VPAC1/VPAC2 receptors. However, both the NH2-terminal and ␣-helical regions of PACAP-27 are required for initiating gallbladder contraction. PAC1 receptor; VPAC1 receptor; VPAC2 receptor; splice variant PITUITARY ADENYLATE cyclase-activating polypeptide (PACAP) is a member of the secretin/glucagon/vasoactive intestinal polypeptide (VIP) family of peptides (2, 8). It occurs in two bioactive molecules (PACAP-38 and PACAP-27) with identical NH 2 -terminal sequences. PACAP-27 has a 68% sequence homology to VIP, and all are expressed in the central as well as peripheral and enteric nervous systems (2, 22). They are released from nerve terminals as neurotransmitters or neuromodulators and regulate the function of the brain and peripheral organs. PACAP exhibits protean biological effects on the gastrointestinal tract, including motility, secretion, and blood flow (6). PACAP and VIP are coexpressed in nerve fibers and neurons in the ganglia of the guinea pig gallbladder (7). Although both peptides act primarily as inhibitory transmitters on most gastrointestinal and vascular smooth muscle cells (5, 6, 12) , their actions on the gallbladder are opposite; VIP relaxes the gallbladder, whereas PACAP induces the contraction both in vivo (9) and in vitro (15, 23, 24) .
]VIP, induced relaxation. In the presence of a PAC1 receptor antagonist, PACAP (6 -38) , the contractile response to PACAP-27 was inhibited and relaxation became evident. RT-PCR analysis revealed abundant expressions of PAC1 receptor, "hop" splice variant, and VPAC1 and VPAC2 receptor mRNAs in the guinea pig gallbladder. In conclusion, PACAP-27 induces contraction of the gallbladder via PAC1/hop receptors. Gly 4 and Ile 5 are the key NH2-terminal residues of PACAP-27 that distinguish PAC1/hop receptors from VPAC1/VPAC2 receptors. However, both the NH2-terminal and ␣-helical regions of PACAP-27 are required for initiating gallbladder contraction. PAC1 receptor; VPAC1 receptor; VPAC2 receptor; splice variant PITUITARY ADENYLATE cyclase-activating polypeptide (PACAP) is a member of the secretin/glucagon/vasoactive intestinal polypeptide (VIP) family of peptides (2, 8) . It occurs in two bioactive molecules (PACAP-38 and PACAP-27) with identical NH 2 -terminal sequences. PACAP-27 has a 68% sequence homology to VIP, and all are expressed in the central as well as peripheral and enteric nervous systems (2, 22) . They are released from nerve terminals as neurotransmitters or neuromodulators and regulate the function of the brain and peripheral organs. PACAP exhibits protean biological effects on the gastrointestinal tract, including motility, secretion, and blood flow (6) . PACAP and VIP are coexpressed in nerve fibers and neurons in the ganglia of the guinea pig gallbladder (7) . Although both peptides act primarily as inhibitory transmitters on most gastrointestinal and vascular smooth muscle cells (5, 6, 12) , their actions on the gallbladder are opposite; VIP relaxes the gallbladder, whereas PACAP induces the contraction both in vivo (9) and in vitro (15, 23, 24) .
Three receptor subtypes that recognize PACAP and VIP have been identified (4, 22) , and all belong to the group of seven transmembrane G protein-coupled receptors. The PACAP-specific (PAC 1 ) receptor has a much higher affinity for PACAP than VIP, whereas the classical VIP (VPAC 1 ) receptor and VPAC 2 receptor exhibit similar affinities for PACAP and VIP. VPAC 1 and VPAC 2 receptors lead to activation of the adenylate cyclase/cAMP pathway in which elevation of intracellular cAMP, together with nitric oxide, mediates relaxation of intestinal and vascular smooth muscle cells (6, 22) . PAC 1 receptors, on the other hand, can activate the dual-signal transduction pathways involving adenylate cyclase and phospholipase C. The activation of the latter probably leads to inositol trisphosphate (IP 3 )-mediated Ca 2ϩ mobilization and protein kinase C mediated-gallbladder contraction (14) , although until now it was not known which receptor subtype is expressed in the gallbladder.
PACAP and related peptides, except helodermin, show no stable structures in aqueous solution (3, 25) . However, in more hydrophobic environments, i.e., in 30 -50% trifluoroethanol, PACAP-38 has a stable structure consisting of three welldefined domains: an initial disordered NH 2 -terminus of eight residues, a central ␣-helical region from Ser 9 (20) . These structural features define specific spatial arrangements of charged residues when they interact with their receptors. Because PACAP-27 has a 68% sequence homology to VIP, the difference in their interaction with PAC 1 receptors must reside in the nine amino acid residues that differentiate the two peptides (Table 1) . In this study, using guinea pig gallbladder smooth muscle strips, we have attempted to identify key residues for interaction of PACAP with PAC 1 receptors by exchanging amino acid residues of PACAP-27 with those of VIP and vice versa. We have also determined the PACAP and VIP receptor subtypes expressed in the guinea pig gallbladder.
MATERIALS AND METHODS
Peptide synthesis. From a consideration of the sequence homology of PACAP and VIP and the results based on the studies by NMR (25) , the positions 4, 5, 6, 8, 9, 13, 21, 24, 25, and 26 of PACAP-27 and the positions 4, 5, 9, 11, and 13 of VIP were selected as substitution points for the present study (Table 1 ). Peptides were synthesized by a simultaneous multiple solid-phase peptide synthesizer (PSSM-8; Shimadzu, Kyoto, Japan), using the 9-fluorenylmethoxycarbonyl strategy as described previously (1) . After simultaneous cleavage with a trifluoroacetic acid cocktail, quantitative amounts of the desired crude peptides were obtained, which were purified by a single step of reverse phase-HPLC and characterized by mass spectrometry, sequence analysis, and amino acid analysis.
Biological actions. This study was approved by the Ethical Committees of Nagoya University and National Institute for Physiological Sciences on Animal Use for Experiment. Male guinea pigs of Hartley strain (450 -580 g) were killed by stunning and exsanguination. The gallbladder was excised, and four smooth muscle strips (1.2 ϫ 10 mm) were prepared under a binocular microscope. They were then suspended in a horizontal organ bath containing 4 ml of Krebs-Ringer solution (pH 7.4), maintained at 37 Ϯ 0.5°C, and aerated with 95% O 2-5% CO2. One end of each muscle strip was fixed to a Silastic rubber bed. The other end was connected to an isotonic displacement transducer (model 45347; NEC-Sanei, Tokyo, Japan) via an L-arm, to which a piezo electric element (100 Hz with movement of 50 m) was applied to minimize the friction (10) . The length of each strip was recorded on a pen recorder (NEC-Sanei) via a computer-controlled data-acquisition system (MacLab, Analog Digital Instruments, Castle Hill, Australia). After we set the initial tension at 500 mg, we allowed muscle strips to equilibrate for 60 min. ACh (Sigma; 10 Ϫ9 to 10 Ϫ4 M) was added to the bathing solution to observe the maximal contraction of each muscle strip. After strips were washed, PACAP-27, PACAP-38, VIP (10 Ϫ10 to 3 ϫ 10 Ϫ7 M; Peptide Institute, Osaka, Japan), or their hybrid peptides (10 Ϫ9 to 3 ϫ 10 Ϫ7 M) were added to the bath. To understand a possible site of action of PACAP-27, atropine (muscarinic receptor antagonist), tetrodotoxin (Na ϩ channel blocker), loxiglumide (CCK-A receptor antagonist), or PACAP(6 -38) (PAC 1 receptor antagonist) was administered before PACAP-27.
RT-PCR and sequence analysis. Total RNA was extracted by the RNeasy-Protect mini kit (Qiagen). We performed reverse transcription using an oligo(dT) primer and TaqMan reverse transcription reagents (Roch, Branchburg, NJ). PCR amplification was performed with the following primers with high sequence homology among human, mouse, and rat receptors: 1) PAC1 receptor (GenBank accession no. NM 001118) sense, 5Ј-GAATGACAGCACAGCTCTGTG-3Ј; antisense, 5Ј-AGTAACGGTTCACCTTCCAGC-3Ј (374 bp); 2) VPAC1 receptor (GenBank accession no. NM 004624) sense, 5Ј-GGAAGTACTTCTGGGGGTACA-3Ј; antisense, 5Ј-CCATTGAG-GAAGCAGTAGAGG-3Ј (423 bp); and 3) VPAC 2 receptor (GenBank accession no. NM 003382) sense, 5Ј-CAGGAAACATAAG-CAAAAACTG-3Ј; antisense, 5Ј-GTGCAGCTTCCTGAAGAG-3Ј (209 bp).
PCR was carried out in a 50-l reaction mixture containing 50 ng cDNA, 5 l of 10ϫ ExTaq buffer, 4 l of 2.5 mM dNTP mix, 50 pmol of each primer, and 1.5 U of ExTaq DNA polymerase (TaKaRa, Otsu, Japan). The conditions were as follows: denaturation for 3 min at 94°C, 30 cycles of denaturation for 30 s at 94°C, annealing for 1 min at 60°C, and extension for 30 s at 72°C; we then followed this by 7 min at 72°C using GeneAmp PCR system 9700 (Applied Biosystems, Foster, CA). PCR products were subjected to electrophoresis on 2% agarose gel. PCR products were purified with the High Pure PCR product purification kit (Roche Diagnostics, Mannheim, Germany) and sequenced directly with an automated sequencer (Beckman Coulter, Fullerton, CA) after terminator reaction using a DNA sequencing kit (CEQ DTCS-Quick Start kit; Beckman Coulter).
Data and statistical analyses. Each muscle strip response to the peptides was standardized as a percentage of the contraction induced by the control: ACh (10 Ϫ4 M) for PACAP and VIP, PACAP-27 (10 Ϫ7 M) for PACAP analogs, and VIP (10 Ϫ7 M) for VIP analogs. All data are presented as means Ϯ SE. The mean of four smooth muscle strips of each animal was used for analysis with n ϭ the number of guinea pigs. The one-way factorial ANOVA, multiple comparison tests (Newman-Keuls), and paired t-test were used to compare the peak responses after peptides were added. P Ͻ 0.05 was chosen as the level of significance.
RESULTS
Effects of PACAP-27, PACAP-38, and VIP. PACAP-27 induced a biphasic response, a large contractile response followed by a very weak relaxation, in guinea pig gallbladder smooth muscle strips (Fig. 1) . The contractile response was dependent on the concentration of PACAP-27. The peak contraction (1.13 Ϯ 0.16 mm) induced by PACAP-27 (10 Ϫ7 M) was ϳ20% of the maximal contraction (5.94 Ϯ 0.80 mm) induced by ACh (10 Ϫ4 M). PACAP-38 induced a contractile response similar to PACAP-27, but it was much less potent than PACAP-27. VIP, on the other hand, induced concentration-related relaxation of the muscle strips. The contractile responses to PACAP-27 were not affected by atropine (10 M was similar to that to PACAP-27 (ϳ80%), but no further increase in activity was observed at 3 ϫ 10 Ϫ7 M (Fig. 3) 21 ]PACAP-27 were ϳ75%, ϳ30%, and ϳ13% of the response to PACAP-27 at 10 Ϫ7 M, respectively. In addition, the contraction period was shortened and was associated with Effects of VIP analogs. All of the NH 2 terminus-substituted VIP analogs induced a concentration-related relaxation of gallbladder smooth muscle strips. Their responses at 10 Ϫ7 M showed no significant difference from those at 10 Ϫ7 M VIP (Fig. 4) . A complete replacement of the NH 2 terminus of VIP with that of PACAP-27, i.e., [Gly 4 , Ile 5 , Ser 9 ]VIP or PACAP(1-9)-VIP(10 -28), also failed to exhibit a PACAP- 27-like contraction. However, at a higher concentration (3 ϫ 10 Ϫ7 M), the relaxation response was less. Substitution in the central domain, [Ser 11 ]VIP, induced a smaller response at 3 ϫ 10 Ϫ7 M. Effects of PACAP (6 -38) . PACAP(6 -38), a partial PAC 1 receptor antagonist, caused significant (P Ͻ 0.01) concentration-related contraction (0% at 10 Ϫ8 M, 5.6 Ϯ 1.2% at 10 Ϫ7 M, and 22.3 Ϯ 1.1% at 10 Ϫ6 M) of gallbladder smooth muscle strips (Fig. 5) . A prior administration of PACAP(6 -38) induced a concentration-related reduction of the contractile response to PACAP-27 (10 Ϫ7 M). Relaxation after the contractile response to PACAP-27 was significant at 10 Ϫ7 M and 10
Ϫ6
M PACAP(6 -38). Significant relaxant effects of PACAP-27 (10 Ϫ8 to 3 ϫ 10 Ϫ7 M) were evident in the presence of PACAP(6 -38) (10 Ϫ6 M) (Fig. 6) .
PAC 1 , VPAC 1 , and VPAC 2 receptor expression. Figure 7 shows RT-PCR analysis of PAC 1 , VPAC 1 , and VPAC 2 receptor mRNAs in the guinea pig gallbladder. Compared with the pancreas and pancreatic duct, all three receptor transcripts were abundantly expressed in the gallbladder. Sequence analysis of a region of guinea pig PAC 1 receptor encoding from the fifth transmembrane domain to the NH 2 -terminal intracellular domain revealed a high homology (91% in nucleotide sequence and 99% in amino acid) to human PAC 1 receptor (Table 2 ). In addition, there was an isoform of guinea pig PAC 1 receptor that contained an additional 84 nucleotides encoding 28 amino acids at the COOH-terminal end of the third intracellular loop. The nucleotide and amino acid sequences of the regions of guinea pig VPAC 1 and VPAC 2 receptors also had high homologies to the respective human (90% and 95%), rat (91% and 93%), and mouse (93% and 91%) sequences.
DISCUSSION
In the present study, we used isotonic transducers, which, by choosing an appropriate weight load, allowed us simultaneous measurements of both contractile and relaxant activities of the gallbladder smooth muscle strips. In agreement with previous studies (15, 23, 24) , PACAP induced contraction of the muscle strips that was followed by relaxation, whereas VIP consistently induced relaxation (Figs. 1 and 2) . The stimulatory effect of PACAP-27 was independent of cholinergic nerves (15) and CCK (this study), the two major regulatory mechanisms of the gallbladder motility, but was significantly inhibited by PACAP(6 -38), a PACAP-receptor antagonist (Figs. 5 and 6) . It has been shown that the relaxant effect of a high concentration of PACAP-27 (10 Ϫ6 M) can be partially blocked by a PACAP-receptor antagonist as well as by a VIP-receptor antagonist (15) . Taken together, it appears that PACAP-27 induces the gallbladder contraction directly via PACAP receptors and the relaxation via both PACAP receptors and PACAP/VIP common receptors. Abundant expressions of PAC 1 , VPAC 1 , and VPAC 2 receptor mRNAs in the guinea pig gallbladder (Fig. 7) support this interpretation. Physiological functions of PAC 1 , VPAC 1 , and VPAC 2 receptors are not yet fully understood. In the present study, the gallbladder contraction was initiated by a 10-fold higher concentration of PACAP-27 than that of VIP (10 Ϫ9 M), which causes relaxation (Fig. 1) . At lower concentrations (10 Ϫ9 to 10 Ϫ8 M), the stimulatory and inhibitory effects of PACAP-27 appear to be balanced, resulting in no gallbladder response. Thus, under physiological conditions, when cholinergic and Fig. 7 . Top: RT-PCR analysis of PAC1, VPAC1, and VPAC2 receptor mRNAs in the guinea pig gallbladder, pancreas, and pancreatic duct. Bottom: deduced amino acid sequences of PAC1 receptor (a) and its isoform (b). G, gallbladder; P, pancreas; D, pancreatic duct; TM, predicted transmembrane domain; GAPDH, glyceraldehyde 3-phosphate dehydrogenase (positive control using GAPDH-specific primers, 452 bp). 3 productions of these peptides has been observed in a rat tumor cell line, AR4 -2J cells (18) . The binding of PACAP-27 to PAC 1 receptors and cAMP production occur in the range of 10 Ϫ9 to 10
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M (1, 16, 18) . The gallbladder stimulatory effect of PACAP-27 was observed in a higher concentration range (10 Ϫ8 to 10 Ϫ6 M) in this study and in earlier studies (15, 23) . At these concentrations, intracellular signal transduction pathways were probably fully activated and the reduction of the binding affinity might not have influenced the biological response.
Unexpectedly, when Gly 4 -Ile 5 was replaced with Ala 4 -Val 5 , the contractile activity of PACAP-27 was completely lost and only the relaxation was induced (Fig. 2) (19) . Among the four splice variants of human PAC 1 receptors, the hop variant had a fivefold greater efficacy in IP 3 production than the authentic PAC 1 receptor (16) . Because PACAP induces relaxation of smooth muscles in most of the tissues that express PAC 1 receptors (6), the expression of the hop variant of PAC 1 receptor might be related to the contractile response observed in the gallbladder. Further studies are necessary to identify the cellular localizations of PAC 1 receptors, the hop variant, and VPAC 1 and VPAC 2 receptors in the gallbladder.
In conclusion, our study has demonstrated abundant expressions of PAC 1 receptor, its hop variant, and VPAC 1 and VPAC 2 receptor mRNAs in the guinea pig gallbladder. PACAP-27 induces contraction of the gallbladder smooth muscles via PAC 1 and/or its hop variant receptors. The positions 4 and 5 are the key NH 2 -terminal residues of PACAP-27 that distinguish PAC 1 /hop receptors from VPAC 1 /VPAC 2 receptors in the gallbladder. However, both the NH 2 -terminal disordered region and ␣-helical region of PACAP-27 are required for initiating gallbladder contraction. Tissue-specific expressions of PACAP and VIP and their receptors determine the net functions of PACAP and VIP.
